Liana Moussatos


Wedbush Offers Commentary on Two Biotech Stocks: XOMA Corp (XOMA), Intercept Pharmaceuticals Inc (ICPT)

Analyst Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 100 analysts rated on TipRanks. Today, Moussatos provided commentary …

Wedbush Slashes Price Target For XOMA Corp Following Changes In The Company’s Pipeline

In a research report released Friday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Xoma Corp (NASDAQ:XOMA), while slashing the …

Wedbush Reiterates Outperform on Lexicon Pharmaceuticals, Inc. Ahead of TELESTAR Presentation at ECC Conference

In a research report released Monday, Wedbush’s healthcare analyst Liana Moussatos reiterated an Outperform rating on shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) with a $19 …

Wedbush Remains Positive on Pacira Pharmaceuticals Inc Despite EXPAREL August Volume Slowdown

Wedbush analyst Liana Moussatos weighed in today with her views on Pacira Pharmaceuticals Inc (NASDAQ:PCRX), as Symphony Health’s EXPAREL volume and sales estimates for August decreased …

Analysts Remain Bullish on Sangamo Biosciences, Inc. (SGMO) Following Restructuring Collaboration Announcement

Yesterday, Sangamo Biosciences, Inc. (NASDAQ:SGMO) announced it will be restructuring its collaboration with Shire PLC (ADR) (NASDAQ:SHPG) in order to speed up the …

Wedbush Offers Commentary On Sangamo Biosciences, Inc. (SGMO) as it Regains Rights to Hemophilia Program

Wedbush analyst Liana Moussatos weighed in today with a few insights on Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the company announced that it has regained the rights …

Wedbush Maintains Outperform on Intercept Pharmaceuticals Inc (ICPT) on Back of FDA Priority Review for OCA

In a research report released today, Wedbush analyst Liana Moussatos maintained an Outperform rating on shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), with a fair value estimate of $493, …

Wedbush Reiterates Outperform on Pacira Pharmaceuticals Inc (PCRX) Following Symphony Health Prescription Estimate

In a research report released Wednesday, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX) with a price …

Wedbush Raises Price Target For Omeros Corporation (OMER) On Back Of Positive OMS721 Phase 2 Data

In a research report released today, Wedbush analyst Liana Moussatos reiterated an Outperform rating on shares of Omeros Corporation (NASDAQ:OMER) and raised the price …

Analysts Bullish on Omeros Corporation (OMER) Following Positive Additional Data for OMS721

Omeros Corporation (NASDAQ:OMER) shot up more than 60% in pre-market trading on Tuesday after the pharmaceutical company announced additional positive data for OMS721 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts